MétaCan
Menu
Retour à la cohorte
Enregistrement W2604236951 · doi:10.1158/1557-3125.dnarepair16-pr05

Abstract PR05: Distinct BRCA1- and BRCA2-specific functions at stalled replication forks: Clinical implications for differences between BRCA1 and BRCA2 mutation-driven cancer

2017· article· en· W2604236951 sur OpenAlexaboutno aff
Haohui Duan, Rachel Reed, Judy E. Garber, Shailja Pathania

Notice bibliographique

RevueMolecular Cancer Research · 2017
Typearticle
Langueen
DomaineBiochemistry, Genetics and Molecular Biology
ThématiqueCRISPR and Genetic Engineering
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésBRCA2 ProteinBiologyMutationCancer researchDNA replicationDNA repairSuppressorBreast cancerGeneCancerCell biologyGeneticsGermline mutation

Résumé

récupéré en direct d'OpenAlex

Abstract BRCA1 and BRCA2 are tumor suppressor genes, and germ line mutations in these two genes increase the risk of breast cancer. Both BRCA1 and BRCA2 are required for stabilization and repair of stalled replication forks. Stalled forks, when not resolved, lead to mutations, or collapse into double strand breaks (DSBs). Both outcomes result in what is commonly referred to as replication stress (RS), which, when chronic, is a driving force behind cancer development. However, it is not clear what are the differences, if any, between BRCA1 and BRCA2 dependent stabilization and repair of stalled replication fork. Getting a better understanding of how these two proteins help suppress RS will not only help reveal how they contribute to breast cancer suppression, but will also give us an insight into the differences in the spectrum of cancers in BRCA1 and BRCA2 mutation carriers. Such knowledge is also critical in designing better therapeutic options for BRCA1 and BRCA2 specific mutation carriers. Here we report a novel role for BRCA2 in suppressing RS by regulating RPA (replication protein A) accumulation on ssDNA (single stranded DNA) at stalled forks. More specifically, we show that BRCA2 is required for efficient turnover of RPA, and in absence of BRCA2 there is “persistent” accumulation of mostly un-phosphorylated RPA (at S33, T21 and S4/S8) at stalled forks. Furthermore, inefficient turnover of RPA in absence of BRCA2 not only results in fork collapse, as marked by increased accumulation of both 53BP1 and Mre11 at the site of stalling, but also leads to suppression of nucleotide excision repair (NER). No such persistent RPA coated ssDNA is observed in BRCA1 depleted cells, suggesting that this intermediate is exclusive to BRCA2 deficiency. We also show that generation of this intermediate was not dependent on Mre11 implying that accumulation of RPA coated ssDNA was not a result of excessive DNA processing by Mre11 exonuclease in absence of BRCA2. To determine whether stalled fork repair (SFR) is defective in normal/healthy breast cells from BRCA2 mutation carriers (BRCA1mut/+), we generated 12 primary mammary epithelial cell (MECs) strains from prophylactic mastectomies performed on BRCA2 mutation carrying women. BRCA2+/+ control MECs were derived from tissue collected during reduction mammoplasties. Our current data shows that BRCA2mut/+ strains are defective in SFR. Importantly, we also show that BRCA2mut/+ strains, and not BRCA1mut/+ strains, are haploinsufficient for NER. Inefficient NER in BRCA2mut/+ strains, and not in BRCA1mut/+ strains, suggests an increased risk in BRCA2 mutation carriers for accumulating DNA lesions that require NER for repair. Such a defect is known to contribute towards increased risk for melanoma, and could partly explain why women with BRCA2 mutation, and not BRCA1 mutation, are prone to increased risk for skin lesions including melanoma. This mechanistic difference between BRCA1 and BRCA2 response at stalled replication forks, and subsequently a crosstalk with NER pathway, might also contribute towards other clinical differences observed in BRCA1 and BRCA2 mutation driven breast cancer. This abstract is also being presented as Poster A35. Citation Format: Haohui Duan, Rachel Reed, Judy Garber, Shailja Pathania. Distinct BRCA1- and BRCA2-specific functions at stalled replication forks: Clinical implications for differences between BRCA1 and BRCA2 mutation-driven cancer [abstract]. In: Proceedings of the AACR Special Conference on DNA Repair: Tumor Development and Therapeutic Response; 2016 Nov 2-5; Montreal, QC, Canada. Philadelphia (PA): AACR; Mol Cancer Res 2017;15(4_Suppl):Abstract nr PR05.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: aucune
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,602
Score d'incertitude au seuil0,751

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0010,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0010,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,119
Tête enseignante GPT0,482
Écart entre enseignants0,363 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2017
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueMolecular Cancer ResearchMême sujetCRISPR and Genetic EngineeringTravaux en français237 207